CERo Therapeutics Holdings, Inc. Common Stock (CERO) — Defensive Interval Ratio
CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Defensive Interval Ratio of 24 days as of June 2025. Defensive assets of $500.00K (cash $-, short-term investments $500.00K, receivables $-) cover 24 days of daily cash needs of $20.87K/day. See CERo Therapeutics Holdings, Inc. Common (CERO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
CERo Therapeutics Holdings, Inc. Common Stock Defensive Interval Ratio (2023–2023)
This chart shows how CERo Therapeutics Holdings, Inc. Common Stock's Defensive Interval Ratio has evolved across 1 annual periods from 2023 to 2023. As of June 2025, the ratio stands at 24 days, meaning defensive assets of $500.00K can fund 24 days of operations without new revenue. See CERo Therapeutics Holdings, Inc. Common balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for CERo Therapeutics Holdings, Inc. Common Stock (2023–2023)
The table below presents the year-by-year Defensive Interval Ratio for CERo Therapeutics Holdings, Inc. Common Stock from 2023 to 2023, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CERo Therapeutics Holdings, Inc. Common stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 595 days | $8.44 Million | $14.17K/day | $- | $8.44 Million | — |